Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mact who started this subject	8/19/2003 9:20:33 AM
From: tom pope	of 510

Briefing: 09:10 ET CIPH Ciphergen Biosys initiated at TWP with Outperform and $13.65 target (8.16) Thomas Weisel Partners is initiating coverage on CIPH with an Outperform rating and $13.65 price target. The firm says its position in the fastest growing sector of research is driving 50% growth. Also, high consumable business model may drive significant multiple expansion. The firm says its business model is compelling with a high level of recurring revenue.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next